Cargando…
Synergistic targeting of immunologic pathways to empower durable tolerance therapies
Autor principal: | Nepom, Gerald T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478166/ https://www.ncbi.nlm.nih.gov/pubmed/36119087 http://dx.doi.org/10.3389/fimmu.2022.962177 |
Ejemplares similares
-
Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability
por: Mao, Wendy
Publicado: (2022) -
Approaches to Establishing Tolerance in Immune Mediated Diseases
por: Huffaker, Michelle F., et al.
Publicado: (2021) -
Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease
por: Ness, Sara, et al.
Publicado: (2021) -
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease
por: Donato, Veronica, et al.
Publicado: (2022) -
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance
por: Maulloo, Chitavi D., et al.
Publicado: (2021)